Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Olezarsen is an apolipoprotein C-III-directed antisense oligonucleotide indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome or severe hypertriglyceridemia, and to reduce acute pancreatitis risk in the latter. Olezarsen is an antisense oligonucleotide directed against apolipoprotein C-III (apoC-III) mRNA, conjugated to a ligand containing three N-acetylgalactosamine (GalNAc) residues to enable delivery to hepatocytes.
- Mechanism
- Curator reviewed · 2 references
Apolipoprotein C-III (APOC3, apoC-III) regulates the uptake of triglyceride-rich lipoproteins in the liver via lipoprotein lipase (LPL)-dependent and LPL-independent mechanisms. Apart from this important role, apoC-III has also been implicated in pathophysiological reactions such as vessel wall inflammation and hypertriglyceridemia, making it a desirable therapeutic target in disease and drug research.
Olezarsen is an ASO-GalNAc3 conjugate that binds to apoC-III mRNA leading to mRNA degradation and resulting in a reduction of serum apoC-III protein. Reduction of apoC-III protein leads to increased clearance of plasma triglycerides and very-low-density lipoprotein (VLDL).
- Primary indication
- Olezarsen is indicated as an adjunct to diet: - to reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). - to reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridemia...Curator reviewed · 3 structured indications
- First approval
- Canada, 2026 · United States, 2024 · European Union, 2025
- Also known as
- ALL-P-AMBO-5'-O-(((6-(5-((TRIS(3-(6-(2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYLOXY)HEXYLAMINO)-3-OXOPROPOXYMETHYL))METHYL)AMINO-5-OXOPENTANAMIDO)HEXYL))PHOSPHO)-2'-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3'-O->5'-O)-2'-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3 · DNA, D(P-THIO)((2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RU-M5C-T-T-G-T-M5C-M5C-A-G-M5C-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETH · IONIS-APOCIII-LRX · ISIS-APOCIII-LRX
- Code names
- AKCEA-APOCIII-LRx · ISIS-678354
- Brand names
- Tryngolza
Resolves to
What you can answer from here — as of November 02, 2026
Which drugs share a target with Olezarsen, and which of those have an active Phase 3 trial?